Not all GLP-1 medications are the same, and not all are approved for adolescents. Currently, two GLP-1 receptor agonists have received FDA approval for chronic weight management in adolescents aged 12 and older, Wegovy® and Saxenda®. Zepbound® is FDA-approved for chronic weight management in adults 18+ but is not FDA-approved for adolescents. Here's what parents should know about each option.
Medication choice for adolescents should be made by a licensed clinician according to current FDA labeling. Compounded semaglutide and tirzepatide are not FDA-approved.
FDA-approved options
Wegovy® (semaglutide)
Saxenda® (liraglutide)
Zepbound® (tirzepatide)
A note on compounded medications
You may have seen advertisements for "compounded semaglutide" or "generic GLP-1" at lower prices. These are not FDA-approved, have not been tested in adolescent clinical trials, and lack the quality controls of brand-name medications.
Thryvwell exclusively prescribes FDA-approved medications with established safety profiles in adolescent populations. When it comes to developing bodies, clinical evidence matters more than cost savings.
Wondering if this applies to your child? The 2-minute eligibility check tells you if Thryvwell could be a fit. No commitment, no payment info.
How your child's physician chooses
The medication selection is individualized based on:
This isn't a one-size-fits-all decision. Your child's physician will discuss the options and recommend the best fit during the clinical intake.
Sources
- FDA. Wegovy® Prescribing Information (2022)
- FDA. Saxenda® Prescribing Information: Pediatric Indication (2020)
- Eli Lilly. Zepbound® prescribing information; adolescent clinical trials are ongoing.
- Weghuber, D. et al. NEJM (2022); Kelly, A.S. et al. NEJM (2020)
Find out which option is right for your child
Our physicians will recommend the best medication based on your child's individual needs
The information on this page is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment.
